Inhibition of Mitochondrial Complex II by the Anticancer Agent Lonidamine
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Inhibition of Mitochondrial Complex II by the Anticancer Agent Lonidamine
Authors
Keywords
-
Journal
JOURNAL OF BIOLOGICAL CHEMISTRY
Volume 291, Issue 1, Pages 42-57
Publisher
American Society for Biochemistry & Molecular Biology (ASBMB)
Online
2015-11-01
DOI
10.1074/jbc.m115.697516
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Targeting mitochondria metabolism for cancer therapy
- (2015) Samuel E Weinberg et al. Nature Chemical Biology
- Cancer Metabolism: New Validated Targets for Drug Discovery
- (2015) Federica Sotgia et al. Oncotarget
- An update on therapeutic opportunities offered by cancer glycolytic metabolism
- (2014) Carlotta Granchi et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Inhibition of Neuronal Cell Mitochondrial Complex I with Rotenone Increases Lipid β-Oxidation, Supporting Acetyl-Coenzyme A Levels
- (2014) Andrew J. Worth et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Metformin suppresses gluconeogenesis by inhibiting mitochondrial glycerophosphate dehydrogenase
- (2014) Anila K. Madiraju et al. NATURE
- Lonidamine induces intracellular tumor acidification and ATP depletion in breast, prostate and ovarian cancer xenografts and potentiates response to doxorubicin
- (2014) Kavindra Nath et al. NMR IN BIOMEDICINE
- The pentose phosphate pathway and cancer
- (2014) Krushna C. Patra et al. TRENDS IN BIOCHEMICAL SCIENCES
- Mitochondrial oxidative phosphorylation TRAP(1)ped in tumor cells
- (2014) Andrea Rasola et al. TRENDS IN CELL BIOLOGY
- Characterization of the Usage of the Serine Metabolic Network in Human Cancer
- (2014) Mahya Mehrmohamadi et al. Cell Reports
- Metformin inhibits mitochondrial complex I of cancer cells to reduce tumorigenesis
- (2014) William W Wheaton et al. eLife
- Differential effects of complex II on mitochondrial ROS production and their relation to cardioprotective pre- and postconditioning
- (2013) Stefan Dröse BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS
- Development of targeting lonidamine liposomes that circumvent drug-resistant cancer by acting on mitochondrial signaling pathways
- (2013) Nan Li et al. BIOMATERIALS
- Inhibition of glutaminase selectively suppresses the growth of primary acute myeloid leukemia cells with IDH mutations
- (2013) Ashkan Emadi et al. EXPERIMENTAL HEMATOLOGY
- Metabolic targets for cancer therapy
- (2013) Lorenzo Galluzzi et al. NATURE REVIEWS DRUG DISCOVERY
- Metformin Therapy and Risk of Cancer in Patients with Type 2 Diabetes: Systematic Review
- (2013) Monica Franciosi et al. PLoS One
- Mitochondrial complex II, a novel target for anti-cancer agents
- (2012) Katarina Kluckova et al. BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS
- Mitochondrial Complex II Can Generate Reactive Oxygen Species at High Rates in Both the Forward and Reverse Reactions
- (2012) Casey L. Quinlan et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Metabolic Modeling of Dynamic Brain 13C NMR Multiplet Data: Concepts and Simulations with a Two-Compartment Neuronal-Glial Model
- (2012) Alexander A. Shestov et al. NEUROCHEMICAL RESEARCH
- 31P and1H MRS of DB-1 melanoma xenografts: lonidamine selectively decreases tumor intracellular pH and energy status and sensitizes tumors to melphalan
- (2012) Kavindra Nath et al. NMR IN BIOMEDICINE
- Engineering of blended nanoparticle platform for delivery of mitochondria-acting therapeutics
- (2012) S. Marrache et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Metabolic reprogramming in cancer: Unraveling the role of glutamine in tumorigenesis
- (2012) Dania Daye et al. SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
- Pharmacokinetics and biodistribution of lonidamine/paclitaxel loaded, EGFR-targeted nanoparticles in an orthotopic animal model of multi-drug resistant breast cancer
- (2011) Lara Milane et al. Nanomedicine-Nanotechnology Biology and Medicine
- Haem oxygenase is synthetically lethal with the tumour suppressor fumarate hydratase
- (2011) Christian Frezza et al. NATURE
- Targeting cancer metabolism: a therapeutic window opens
- (2011) Matthew G. Vander Heiden NATURE REVIEWS DRUG DISCOVERY
- Therapeutic Efficacy and Safety of Paclitaxel/Lonidamine Loaded EGFR-Targeted Nanoparticles for the Treatment of Multi-Drug Resistant Cancer
- (2011) Lara Milane et al. PLoS One
- Cancer cell killing via ROS: To increase or decrease, that is the question
- (2010) Jie Wang et al. CANCER BIOLOGY & THERAPY
- Specific disintegration of complex II succinate:ubiquinone oxidoreductase links pH changes to oxidative stress for apoptosis induction
- (2010) A Lemarie et al. CELL DEATH AND DIFFERENTIATION
- Mitochondrial Targeting of Vitamin E Succinate Enhances Its Pro-apoptotic and Anti-cancer Activity via Mitochondrial Complex II
- (2010) Lan-Feng Dong et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Targeting mitochondria for cancer therapy
- (2010) Simone Fulda et al. NATURE REVIEWS DRUG DISCOVERY
- Suppression of Tumor Growth In vivo by the Mitocan -tocopheryl Succinate Requires Respiratory Complex II
- (2009) L.-F. Dong et al. CLINICAL CANCER RESEARCH
- Modulation of cellular radiation responses by 2-deoxy-D-glucose and other glycolytic inhibitors: Implications for cancer therapy
- (2009) VijayK Kalia et al. Journal of Cancer Research and Therapeutics
- α-Tocopheryl succinate induces apoptosis by targeting ubiquinone-binding sites in mitochondrial respiratory complex II
- (2008) L-F Dong et al. ONCOGENE
- Determination of cellular redox status by stable isotope dilution liquid chromatography/mass spectrometry analysis of glutathione and glutathione disulfide
- (2008) Peijuan Zhu et al. RAPID COMMUNICATIONS IN MASS SPECTROMETRY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now